Galcanezumab in Refractory Episodic and Chronic Cluster Headache Galcanezumab in Refractory Episodic and Chronic Cluster Headache

This narrative review examines the safety and efficacy of the CGRP galcanezumab in patients with episodic or chronic refractory cluster headache.Headache
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news